Reduced creatine kinase as a central and peripheral biomarker in Huntington’s disease

A major goal of current clinical research in Huntington’s disease (HD) has been to identify preclinical and manifest disease biomarkers, as these may improve both diagnosis and the power for therapeutic trials. Although the underlying biochemical alterations and the mechanisms of neuronal degenerati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Jinho, Amante, Daniel J., Moody, Jennifer P., Edgerly, Christina K., Bordiuk, Olivia L., Smith, Karen, Matson, Samantha A., Matson, Wayne R., Scherzer, Clemens R., Rosas, H. Diana, Hersch, Steven M., Ferrante, Robert J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2893277/
https://ncbi.nlm.nih.gov/pubmed/20460152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbadis.2010.05.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados